Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 8OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Plasma cell 1Lymphoid 1

Conditions

Side-effect of Antibiotic 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Breast Neoplasms 1Bacteremia 1Advanced Breast Cancer 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Moxifloxacin × Clear all
NCT05114720 2025-12-17

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Sun Yat-sen University

Phase 3 Completed
559 enrolled
Breast

Breast Neoplasms

NCT03405168 2018-11-16

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Sun Yat-sen University

Phase 2 Completed
35 enrolled
Breast

Advanced Breast Cancer

NCT00398411 2015-06-29

MoxiProph

University of Cologne

Phase 3 Completed
66 enrolled 15 charts
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Bacteremia

NCT01302951 2011-02-24

MOXI

University Hospital, Saarland

Phase 4 Completed
34 enrolled

Side-effect of Antibiotic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡